UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000037226
Receipt No. R000042441
Scientific Title Goshajinkigan for chemotherapy-induced peripheral neuropathy control : A systematic review
Date of disclosure of the study information 2022/12/01
Last modified on 2019/07/01 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Goshajinkigan for chemotherapy-induced peripheral neuropathy control : A systematic review
Acronym Goshajinkigan for chemotherapy-induced peripheral neuropathy control : A systematic review
Scientific Title Goshajinkigan for chemotherapy-induced peripheral neuropathy control : A systematic review
Scientific Title:Acronym GCPNC
Region
Japan

Condition
Condition chemotherapy-induced peripheral neuropathy
Classification by specialty
Surgery in general Obsterics and gynecology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To examine whether goshajinkigan can be controlled for peripheral neuropathy caused by chemotherapy.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Evaluation index of peripheral neuropathy
1. CTCAE
2. DEB-NTC
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria An outcome report of peripheral neuropathy induced by cancer chemotherapy
Key exclusion criteria Report on peripheral neuropathy induced by other than cancer chemotherapy as outcome
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Makoto
Middle name
Last name Nakano
Organization Yokohama University of Pharmacy
Division name Dep. of Pharmacy
Zip code 245-0066
Address 601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, JAPAN
TEL 045-859-1300
Email m.nakano@hamayaku.ac.jp

Public contact
Name of contact person
1st name Kohsuke
Middle name
Last name Hayamizu
Organization Yokohama University of Pharmacy
Division name Dep. of Pharmacy
Zip code 245-0066
Address 601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, JAPAN
TEL 045-859-1300
Homepage URL
Email k.hayamizu@hamayaku.ac.jp

Sponsor
Institute Yokohama University of Pharmacy
Institute
Department

Funding Source
Organization Yokohama University of Pharmacy
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Yokohama University of Pharmacy
Address 601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, JAPAN
Tel 0458591300
Email kohsuke_hayamizu@nissui.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 12 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2019 Year 02 Month 25 Day
Date of IRB
2019 Year 02 Month 16 Day
Anticipated trial start date
2019 Year 02 Month 25 Day
Last follow-up date
2020 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information e-Search by Database is finished.
Under selection of relevant papers.

Management information
Registered date
2019 Year 07 Month 01 Day
Last modified on
2019 Year 07 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042441